Cellarity Launches Phase 1 Study for Novel Sickle Cell Treatment CLY-124 Cellarity has initiated a Phase 1 clinical trial for CLY-124, an innovative oral medication aimed at treating sickle cell disease with a unique Globin-Switching mechanism.

Cellarity Launches Phase 1 Study for Novel Sickle Cell Treatment CLY-124 #United_States #Somerville #Sickle_Cell #Cellarity #CLY-124

GordonMD Global Investments Appoints Ted Myles as Cellarity CEO Amid Advancement in Scientific Programs GordonMD Global Investments has announced Ted Myles as the new CEO of Cellarity, enhancing leadership amid scientific advancements.

GordonMD Global Investments Appoints Ted Myles as Cellarity CEO Amid Advancement in Scientific Programs #United_States #Beverly_Hills #Cellarity #GordonMD #Ted_Myles

Ted Myles Appointed CEO of Cellarity and CEO-Partner at Flagship Pioneering Ted Myles takes the helm as Cellarity's new CEO, bringing extensive biopharma experience to drive innovation in drug development and clinical research.

Ted Myles Appointed CEO of Cellarity and CEO-Partner at Flagship Pioneering #USA #Cambridge #Biopharma #Flagship_Pioneering #Cellarity